Schematic diagram to show the mechanism of CD69 action on the stem-like and terminally differentiated CD8+ T cells in wild-type and CD69-deficient mice (IMAGE)
Caption
A study to describe the functional mechanism of CD69 in regulating the tumor-specific CD8+ T cell fate in tumor-draining lymph nodes (TDLNs), which can be used to develop a novel anti-CD69 antibody for more efficient cancer immunotherapies in the future
Credit
Ryo Koyama-Nasu and Motoko Y. Kimura from Chiba University
Usage Restrictions
w. credit
License
Original content